Cartesian Therapeutics   Report issue

For profit Phase 1 Phase 2
Founded: Rockville MD United States (2016)

Organization Overview

First Clinical Trial
2018
NCT03448978
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Cartesian Therapeutics